The Wall Street Journal seeks an enterprising and ambitious reporter to cover business in Asia with a primary focus on health and China.
Asia has a thriving pharmaceutical industry in China, India and Japan; companies in the region are major outsourcing partners for counterparts in the West. China has ambitions to become a leader in health technologies such as DNA analysis and gene editing. Asia is also a key battleground for combating lifestyle diseases such as diabetes, monitoring emerging viruses and tackling the health challenges of aging populations. The region continues to confront the Covid-19 pandemic, including with Zero-Covid policies that have disrupted economies and sparked backlashes even as they have in some cases kept case counts relatively low.
- Dive deeply into China’s fast-evolving health landscape, its technological advances and its weaknesses, and the domestic and global companies doing business there.
- Be our Asia point person on the health industry, everything from gene editing to the epidemiology of the fight against Covid-19.
- Range across this multitrillion-dollar regional industry, unearthing newsworthy developments and trends in drug production, medical supply chains, scientific discoveries and more.
- Regularly break news and illuminate important trends. You will need to generate lots of ideas and have the skills needed to see them through.
- Help the team handle the broader, often unexpected corporate news developments that make Asia such an exciting place to work.
- At least five years of journalism experience demonstrating strong reporting skills and a record of breaking news.
- Ideally, previous experience covering health and working in or around China. Fluency in Mandarin is also a strong plus.
- The ability to work collegially as part of a team.
The job is based in either Hong Kong or Singapore and reports to the Asia Business Editor.
To apply, go here.